Related MeSH Hierarchy (4)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Gastrointestinal Neoplasms » Stomach Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Gastrointestinal Neoplasms » Stomach Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastrointestinal Neoplasms » Stomach Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Stomach Diseases » Stomach Neoplasms
Hierarchy View
Approved Indicated Drugs (2)
Phase 1 Indicated Drugs (200)
dec-205/ny-eso-1 fusion protein cdx-1401
ebna1 c-terminal/lmp2 chimeric protein-expressing recombinant modified vaccinia ankara vaccine
her2bi-armed activated t cells
masct:multiple antigens specific cellular therapy
mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes
modified vaccinia virus ankara vaccine expressing p53
mvf-her-2(628-647)-crl 1005 vaccine
nkg2dl-targetting chimeric antigen receptor-grafted gamma delta t cell
personalized neoantigen vaccine
Other Experimental Indicated Drugs (66)
Organization Involved with Phase 4 Indications (38)
Organization Involved with Phase 3 Indications (183)
Anhui College of Traditional Chinese Medicine
A.O. Ospedale Maggiore di Lodi
A.O. Ospedale San Carlo di Potenza
A.O. Ospedale Versilia di Camaiore
Arbeitsgemeinschaft fur Internistische Onkologie (AIO)
ASUR Zona 6 di Fabriano, Oncologia
AUSL di Piacenza, Oncologia Medica
Australasian Gastro-Intestinal Trials Group
Azienda Sanitaria dell'Alto Adige
Blokhin's Russian Cancer Research Center
Boryung Pharmaceutical Company
Cantonal Hospital of St. Gallen
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Daehwa Pharmaceutical Co., Ltd.
Daewoong Pharmaceutical Co. LTD.
Eastern Network of Cancer Immunological Therapy, Japan
European Organisation for Research and Treatment of Cancer
Federation Francophone de Cancerologie Digestive
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Guangdong Pharmaceutical University
Guangdong Provincial Hospital of Traditional Chinese Medicine
Huazhong University of Science and Technology
Innovent Biologics (Suzhou) Co. Ltd.
Ishikawa Prefectural Central Hospital
Istituto Tumori di Bari, Oncologia Medica
Japan Clinical Cancer Research Organization
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Katholieke Universiteit Leuven
Korean Cancer Stusy Group stomach Cancer Committee
Luigi Sacco University Hospital
National Health and Medical Research Council, Australia
National Institutes of Health (NIH)
Osaka International Cancer Institute
Ospedale degli Infermi di Biella
Ospedale Fatebenefratelli di Roma
Ospedale Generale Provinciale di Saronno
Ospedale Misericordia e Dolce, Prato
OSPEDALE POLICLINICO G.B. ROSSI
Ospedale San Vincenzo Taormina
Presidio Socio Sanitario Territoriale di Gorgonzola
Rajiv Gandhi University of Health Sciences
St. Antonius Hospital, Nieuwegein
Swiss Group for Clinical Cancer Research
Taizhou Hanzhong biomedical co. LTD
Technical University of Munich
The First People's Hospital of Changzhou
The Royal Australian and New Zealand College of Radiologists
Tokyo Metropolitan Oncology Group
Trans Tasman Radiation Oncology Group
University of California, Los Angeles
University of Modena and Reggio Emilia
University of Roma La Sapienza
University of Texas at Houston
Organization Involved with Phase 2 Indications (255)
Academic and Community Cancer Research United
Arbeitsgemeinschaft medikamentoese Tumortherapie
Aristotle University of Thessaloniki
Beijing Biohealthcare Biotechnology Co.,Ltd
Beijing Doing Biomedical Co., Ltd.
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Cancer Therapeutics Research Group
Case Western Reserve University
Centre Georges Francois Leclerc
Centre Hospitalier La Source, Orleans
Centre Hospitalier Universitaire Vaudois
Chao Family Comprehensive Cancer Center
Chongqing Precision Biotech Co., Ltd
City of Hope National Medical Center
Desert Regional Comprehensive Cancer Center
Eastern Cooperative Oncology Group
Eastern Hepatobiliary Surgery Hospital
EddingPharm Oncology Co., LTD.
Groupe Hospitalier Paris Saint Joseph
Gruppo Oncologico Italiano di Ricerca Clinica
Hellenic Cooperative Oncology Group
Hellenic Oncology Research Group
Icahn School of Medicine at Mount Sinai
Institut de Cancerologie de l'Ouest Paul Papin
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut Mutualiste Montsouris
Instituto do Cancer do Estado de São Paulo
International Extranodal Lymphoma Study Group
Jilin Provincial Tumor Hospital
Korea Institute of Radiological & Medical Sciences (KIRAMS)
Korean South West Oncology Group
Medical University of South Carolina
Memorial Cancer Institute, Florida
Memorial Sloan-Kettering Cancer Center
National Cheng Kung University
National Comprehensive Cancer Network
National University of Singapore
Norwegian University of Science and Technology
Ospedale S. Giovanni Bellinzona
People's Hospital of Zhongshan
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Radiation Therapy Oncology Group
Seattle Integrative Cancer Center
Second Military Medical University
Shanghai Cell Therapy Research Institute
Shanghai Junshi Bioscience Co.,Ltd.
Shanghai Sunstem Biotechnology Co., Ltd.
Shenzhen Hornetcorn Bio-technology Company, LTD
Simcere Pharmaceutical Co., Ltd
State University of New York, Buffalo
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Taipei Veteran General hospital
Technical University of Dresden
The Second People's Hospital of Sichuan
The University of Texas, Dallas
Universidad Autonoma de Barcelona
University of Alabama, Birmingham
University of California, Berkeley
University of California, Irvine
University of California, San Diego
University of California, San Francisco
University of Medicine and Dentistry of New Jersey
University of Nice Sophia Antipolis
University of North Carolina at Chapel Hill
University of Southern California
University of Texas, Galveston
Washington University in St. Louis
Xiansheng Pharmaceutical Company
Organization Involved with Phase 1 Indications (64)
Cellular Biomedicine Group Ltd.
Guangdong Xiangxue Precision Medical Technology Co., Ltd
Ludwig Institute for Cancer Research
Nanjing Sike Pharmaceutical Co., Ltd.
National University of Ireland
Organization Involved with Other Experimental Indications (20)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
